City of Hope’s Department of Molecular and Cellular Biology, originally Molecular Genetics, was formed in 1982 under the direction of Keiichi Itakura, Ph.D., professor of molecular biology. Research interests in thedepartment include an array of biological systems and problems, but the unifying theme is mechanisms regulating expression of genetic information at both the transcriptional level (where DNA directs the synthesis of RNA) and the post-transcriptional level (meaning how genes control protein synthesis from newly-transcribed RNAs).
The department includes eight independent laboratories as well as theElectron Microscopy core facility, overseen by Marcia Miller, Ph.D. and Zhuo Li, Ph.D.
Investigators within the department actively collaborate with investigators in the medical center, making important contributions to clinical investigations at City of Hope. The faculty also collaborates with the wider academic and scientific community. Faculty members have served numerous leadership roles, including with the National Institutes of Health, American Cancer Society and the Army Breast Cancer Research Program.
Department faculty members also teach and mentor graduate students in City of Hope’sIrell & Manella Graduate School of Biological Sciences. The department offers students the opportunity to carry out research in genetics, developmental biology, molecular genetics, molecular biochemistry, cell biology, molecular virology, and molecular and cellular immunology.
John J. Rossi, Ph.D. - siRNA and ribozymes
The focus of this laboratory is the biology and therapeutic application of small RNAs, with particular emphasis on small interfering RNAs (siRNAs) and ribozymes as therapeutic agents for the treatment of HIV infection.
Adam Bailis, Ph.D. – Genetics and molecular biology
This laboratory uses genetic and molecular biological approaches to study how DNA replication and repair are coordinated in the maintenance of genome stability.
Mark Boldin, M.D., Ph.D. – Noncoding RNA control of mammalian hematopoiesis, immunity and cancer
Research in this lab is focused on the biology of noncoding RNA and the understanding of its role in the regulation of inflammation and cancer using molecular, biological and genetic approaches.
Keiichi Itakura, Ph.D. – Molecular biology
The laboratory of Keiichi Itakura, Ph.D.,studies the role of ARID transcription factors in the development and maturation of adipocytes and carcinogenesis. They also study molecular events in energy balance, as well as the functions of homeobox genes in prostate cancer.
Ren-Jang Lin, Ph.D.– RNA processing and regulatory RNA
The research objectives of this laboratory are two-fold, both centered on RNA: to decipher the molecular mechanism of RNA processing, and to reveal novel roles of RNA in regulating gene expression, with emphasis on aberrant cellular factors linked to human diseases.
Linda Malkas, Ph.D.– DNA replication/repair and human disease
The laboratory focuses on understanding the mechanisms mediating human cell DNA replication and repair and applying these discoveries to the development for new biomarkers and molecular targets for cancer.
Marcia Miller, Ph.D.– Molecular immunogenetics
Oncogenic herpesviruses disproportionately cause tumors in immunocompromised patients. This lab studies how genetic polymorphism influences the incidence of cancers caused by oncogenic herpesviruses.
Piroska Szabo, Ph.D.– Epigenetics
This laboratory investigates the epigenetic mechanisms governing genomic imprinting using methods of genetics, biochemistry and molecular biology. The group is also involved in environmental reproductive epigenetics.
Yeast genetics; post-transcriptional processing
The department maintains extensive expertise in yeast genetics and molecular biology. Studies focus on mechanisms involved in homologous recombination and post-transcriptional processing of premessenger RNAs. Research also includes the development and applications of RNA aptamers regulating diverse processes ranging from pre-mRNA splicing to receptor-mediated delivery of small interfering RNAs (siRNAs) to treat cancer and viral infections.
Defining the epigenetic mechanisms regulating gene expression is vital to understanding both normal development and carcinogenesis. Investigative efforts include determining mechanisms of genetic imprinting and the role of small RNAs in heterochromatin formation. Research on the function of small RNAs is an important program in the department. There is also strong emphasis on how microRNA functions as a post-transcriptional regulator of gene expression. Several laboratories are exploring therapeutic applications of RNA interference.
DNA replication/repair and human disease
Organisms need to safeguard genetic information to prevent the damaging effects of aging and disease. This is accomplished by accurate replication of DNA and by repair of any damage incurred as a result of endogenous or exogenous factors. New exciting details about DNA replication and repair are being discovered. These processes are proving to be highly interconnected, and could lead to treatments for various diseases and age-related disorders.
Biochemistry of DNA damage and repair
Understanding how DNA is damaged, both by mutagens and by treatments such as chemotherapy and radiotherapy, and the mechanisms governing DNA repair or the failure thereof, are essential to progress in developing better prevention and treatment strategies for a variety of cancers.
ARID transcription factors
This class of DNA-binding proteins plays multiple roles in the normal development of a variety of tissues, most prominently fat, bone and muscle. Recent discoveries suggest that these factors help to create activating "bookmarks" in genes that are crucial for establishing and maintaining the identities of these tissues. Therefore, the study of ARID transcription factors may lead to a greater understanding of medical problems ranging from obesity and diabetes to muscular injury, skeletal defects, and cancer.
Genetic influences in responses to cancer and infection
Investigations are underway to elucidate how and by what mechanisms genetic variability determines immune responses to virally-induced lymphomas.
Non-coding RNA control of mammalian hematopoiesis, immunity and cancer
Understanding the molecular mechanisms that govern immune cell development and function is key for the advance of novel therapeutic approaches to treat autoimmunity and cancer. Noncoding RNAs, in particular microRNAs, play a critical role in shaping the mammalian immune response and hematopoiesis, and are the focus of our research interest.
When Ralph Richardson discovered that his prostate-specific antigen (PSA) reading was a 6, he told his primary care physician that he wanted to go to City of Hope. “I felt I was better off in a City of Hope environment, where it’s a cancer treatment specialty hospital. This is what they do,” Richardson said....
A new test that allows researchers to quickly identify drugs and chemicals that could disrupt the balance of hormones in the body – potentially affecting development and progression of cancer, including breast cancer – has raised worries about the common antidepressant Paxil. In a trial screening of 446 comm...
No matter how impressive a research study’s conclusion may be – or how seemingly unsurprising – experts are needed to put the findings into context. Perhaps a study’s methodology wasn’t as strong as it could have been. Perhaps the conclusions confirmed that other researchers are on the right track. Perhaps t...
Research studies known as clinical trials have led to countless advances in the diagnosis, treatment and prevention of cancer. These studies test the effectiveness of new medical approaches that can lead to fewer treatment-related side effects and, in some cases, improved outcomes for patients with certain c...
Many cancer incidence rates decline over time, but kidney cancer is one of the few cancers with incidence rates that continue to rise year after year. Currently, nearly 64,000 new cases of kidney cancer are diagnosed in the United States each year, and approximately 13,860 people die from it, according to t...
Once unknown to most people, HPV, or human papillomavirus, has become a subject of both worry and debate. It’s directly linked to cervical cancer, head and neck and other cancers, but many parents are reluctant to vaccinate their daughters against the disease. City of Hope’s recent “Ask the...
Parenting a child isn’t easy. Parenting a child with cancer can be infinitely more difficult. But parents can’t give up on their basic responsibilities to raise a child properly. In this video, Jeanelle Folbrecht, Ph.D., associate clinical professor of psychology in the Department of Supportive Care Medicine...
When it comes to working out, harder and faster may not always be better. That’s what Sophia Wang, Ph.D., associate professor at City of Hope’s Department of Population Sciences, found about exercise and stroke risk when she looked into the connection between the two. Examining data from more tha...
An epidemic of thyroid cancer in the U.S. is actually an epidemic of diagnosis, conclude the authors of a new report. Their analysis pointed out that, although thyroid cancer diagnoses have nearly tripled during the past 30 years, mortality rates have remained the same. To them, this means the disease has be...
After adjusting to the rigors of a cancer patient’s schedule – a barrage of appointments with surgeons, oncologists, radiologists, chemotherapy treatments, surgeries, tests – cancer survivors have large adjustments to make. “You get into this system where you’re seeing multiple doctors a week – you’re in a g...
A friend’s child has been hospitalized for cancer treatment. You want to visit, but don’t know what to say. You want to help, but don’t know what to do. City of Hope has some advice. In this video series, Jeanelle Folbrecht, Ph.D., associate clinical professor of psychology in the Department of Supportive Ca...
A side effect of cancer treatment many people don’t expect? Weight gain. People with certain cancers – such as breast, prostate and colon cancer – are more likely to gain weight during treatment due to the therapies used to combat their disease. Hormone therapy, some chemotherapy regimens and medications suc...
Humans are exposed to countless chemicals every day, so identifying the ones that can impact their health – specifically the ones that can increase cancer risk – is akin to looking for a sugar crystal in a salt shaker. But that process has now been made much less arduous by researchers at City of Hope. They&...
Despite gradual improvements over the years, brain tumors remain particularly tricky to treat. Treatment can affect normal brain tissue, which can cause physical and cognitive impairment. One particularly challenging obstacle is the blood-brain barrier, which prevents cancer drugs from passing into the brain...
As the nation commemorates Black History Month, a City of Hope researcher is calling attention to the fact that a shocking 15 percent of African-American breast cancer survivors do not receive annual follow-up mammograms after their treatment stops. “We did a preliminary study that informed our current survi...